- Home
- MAIA vs PMVP Comparison
MAIA vs PMVP Comparison
Compare MAIA & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- PMVP
- Stock Information
- Founded
- MAIA 2018
- PMVP 2013
- Country
- MAIA United States
- PMVP United States
- Employees
- MAIA N/A
- PMVP N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MAIA Health Care
- PMVP Health Care
- Exchange
- MAIA Nasdaq
- PMVP Nasdaq
- Market Cap
- MAIA 62.4M
- PMVP 85.5M
- IPO Year
- MAIA 2022
- PMVP 2020
- Fundamental
- Price
- MAIA $2.82
- PMVP $1.65
- Analyst Decision
- MAIA
- PMVP Strong Buy
- Analyst Count
- MAIA 0
- PMVP 4
- Target Price
- MAIA N/A
- PMVP $5.75
- AVG Volume (30 Days)
- MAIA 60.0K
- PMVP 185.0K
- Earning Date
- MAIA 11-05-2024
- PMVP 11-07-2024
- Dividend Yield
- MAIA N/A
- PMVP N/A
- EPS Growth
- MAIA N/A
- PMVP N/A
- EPS
- MAIA N/A
- PMVP N/A
- Revenue
- MAIA N/A
- PMVP N/A
- Revenue This Year
- MAIA N/A
- PMVP N/A
- Revenue Next Year
- MAIA N/A
- PMVP N/A
- P/E Ratio
- MAIA N/A
- PMVP N/A
- Revenue Growth
- MAIA N/A
- PMVP N/A
- 52 Week Low
- MAIA $0.82
- PMVP $1.33
- 52 Week High
- MAIA $5.99
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- PMVP 60.86
- Support Level
- MAIA $2.36
- PMVP $1.63
- Resistance Level
- MAIA $2.72
- PMVP $1.69
- Average True Range (ATR)
- MAIA 0.22
- PMVP 0.07
- MACD
- MAIA 0.02
- PMVP 0.01
- Stochastic Oscillator
- MAIA 72.28
- PMVP 52.65
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.